In Brief: revised NDI draft expected in 2013, MusclePharm invests, Sundial label and GMP warnings, AHPA publishes organic guidance
This article was originally published in The Tan Sheet
Executive Summary
CFSAN plans revised NDI draft in 2013; MusclePharm invests in BioZone delivery tech; Indiana kicks off anti-smurfing campaign; Sundial fails basic labeling, GMP compliance; AHPA advises supplement firms on organic rules; Naturex commits to sustainability; Targeted Medical Pharma expands into supplements.
You may also be interested in...
Time's Up For Sundial Herbs – US Firm Recalls All Products Seven Years After FDA’s Warning
FDA officials, following each Sundial Herbs response since 2013 to the agency stating that it had corrected problems identified during inspections, found continued violations on the firm’s website and in its store. Investigators purchased the firm’s products with violative claims as recently as February.
Energy Drinks Swayed By Liquid Supplement Draft Guidance After All
Monster Energy products will transition from supplement to conventional food labeling, in a sign that industry may be adapting to FDA’s draft guidance on liquid supplements that stirred controversy upon its publication in 2009.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.